Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.
Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...
Zacks Investment Research on MSN
PLSE shares positive first-in-human nPulse cardiac catheter data
Pulse Biosciences PLSE recently announced late-breaking data from its first-in-human feasibility study of the nPulse Cardiac ...
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...
4d
Study finds 90 minutes weekly activity after ablation linked to fewer atrial fibrillation relapses
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...
Patrick Vellner talked about how it felt being awake during the heart ablation procedure and revealed how long the recovery ...
Everyday Health on MSN
Hypertrophic cardiomyopathy (HCM) surgery and procedure options: What to know about septal myectomy, septal ablation, and heart transplant
Learn about surgical options for hypertrophic cardiomyopathy (HCM), including septal myectomy, septal ablation, and heart ...
Lazio have confirmed that head coach Maurizio Sarri has had a successful operation on his heart after being diagnosed with atrial fibrillation. Lazio have confirmed in a statement that Sarri had a ...
Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib) Pulsed field ablation – or ...
DAVENPORT, Iowa (KWQC) - A doctor recently performed the first surgery of its kind in Iowa using new technology to treat atrial fibrillation at MercyOne Genesis. Dr. Mark Shen performed the surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results